ERBB2 and breast carcinoma: The Oncotype DX Breast Recurrence Score Test (Exact Sciences, formerly Genomic Health) is a multigene prognostic assay comprising a multiplex RT-PCR analysis of 16 cancer-related genes and 5 reference genes, developed to assist treatment decisions in ER + /HER2− breast cancer patients8.